Market Place
Sourcing Support
Shineco to Effect 50:1 Reverse Stock Split
07 Aug 2025 //
GLOBENEWSWIRE
Shineco Executives Launch $2M Stock Purchase Program
11 Jun 2025 //
GLOBENEWSWIRE
Shineco Announces Reverse Split to Regain NASDAQ Compliance
12 Nov 2024 //
GLOBENEWSWIRE
Shineco Announces Closing of $2 Million Underwritten Public Offering
15 Jul 2024 //
GLOBENEWSWIRE
Shineco Announces Pricing of $2 Million Underwritten Public Offering
12 Jul 2024 //
GLOBENEWSWIRE
Shineco Announces Proposed Underwritten Public Offering
11 Jul 2024 //
GLOBENEWSWIRE
Shineco Signs $30M+ Distribution Deals For New Health Food Beverage
10 Jul 2024 //
GLOBENEWSWIRE
Shineco Enters Securities Purchase Agreement With $7M Gross Proceeds
24 Jun 2024 //
GLOBENEWSWIRE
Shineco Signs Letter Of Intent To Address China’s Aging Population
20 Jun 2024 //
GLOBENEWSWIRE
Shineco And Turing Video To Jointly Develop Intelligent Health Care Products
17 Jun 2024 //
GLOBENEWSWIRE
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
12 Mar 2024 //
GLOBENEWSWIRE
Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance
14 Feb 2024 //
GLOBENEWSWIRE
Shineco Announces the Appointment of Two New Executive Officers
17 Nov 2023 //
GLOBENEWSWIRE
Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition
30 Oct 2023 //
GLOBENEWSWIRE
Shineco to Increase R&D to Explore New High-Tech Medical Product Applications
04 Oct 2023 //
GLOBENEWSWIRE
Shineco Subsidiary Receives Marketing Approval for Cardiac 5-Minute Test
10 Jul 2023 //
GLOBENEWSWIRE
Shineco Enters into Cooperation Agreement with Kangling Medical
28 Jun 2023 //
GLOBENEWSWIRE
Shineco Subsidiary Registered as a Member of Pharmaceutical Chamber of Commerce
08 Jun 2023 //
GLOBENEWSWIRE
Shineco Entered Into Agreement Relating to Acquisition of Chongqing Wintus
17 Jan 2023 //
GLOBENEWSWIRE
Shineco Subsidiary Receives Prior Approval Supplement “Cardiac 5-Minute Test”
19 Dec 2022 //
GLOBENEWSWIRE
Shineco, Inc Subsidiary, Granted USPTO Patent and FDA Marketing Approval
07 Dec 2022 //
GLOBENEWSWIRE
Shineco, Inc. Attends MEDICA 2022 Düsseldorf Germany
29 Nov 2022 //
GLOBENEWSWIRE
Shineco to Acquire Controlling Equity Interest in Changzhou Biowin
25 Oct 2022 //
GLOBENEWSWIRE
Shineco, Inc. to Acquire Controlling Equity Interest in Changzhou Biowin
25 Oct 2022 //
BIOSPACE
Shineco, Inc. Announces Director Change
18 Aug 2022 //
GLOBENEWSWIRE
Shineco Enters into Securities Purchase Agreement with Gross Proceeds of US$2.2M
14 Apr 2022 //
GLOBENEWSWIRE
Shineco, Inc. Announces Board and Officer Changes
28 Mar 2022 //
GLOBENEWSWIRE
Shineco Plans to Introduce Private Equity Fund to Help Business Transition
18 Mar 2022 //
GLOBENEWSWIRE
Shineco to Build Tumor Diagnosis and Treatment Center in Shandong Province
11 Mar 2022 //
GLOBENEWSWIRE
Shineco, Inc. Announces New Website Launch
03 Mar 2022 //
GLOBENEWSWIRE
Shineco to Create an Industry-University-Research-Medical Collaborative Platform
24 Feb 2022 //
GLOBENEWSWIRE
Shineco Announces Strategic Alliance to Enhance R&D in Innovation
17 Feb 2022 //
GLOBENEWSWIRE
Shineco Enters Into Cooperation Agreement to Jointly Manufacture PET
03 Feb 2022 //
GLOBENEWSWIRE
Shineco Appoints Professor Qiyin Sun as Chief Medical Consultant
01 Feb 2022 //
GLOBENEWSWIRE
Shineco to Acquire 51% Equity in Xiang Peng You Kang
18 Jan 2022 //
GLOBENEWSWIRE
Shineco Intends to Acquire a Controlling Interest of Xiang Peng You Kang
03 Dec 2021 //
GLOBENEWSWIRE
